GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (LSE:RENE) » Definitions » Gross Profit

ReNeuron Group (LSE:RENE) Gross Profit : £0.25 Mil (TTM As of Sep. 2023)


View and export this data going back to 2005. Start your Free Trial

What is ReNeuron Group Gross Profit?

ReNeuron Group's gross profit for the six months ended in Sep. 2023 was £0.16 Mil. ReNeuron Group's gross profit for the trailing twelve months (TTM) ended in Sep. 2023 was £0.25 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. ReNeuron Group's gross profit for the six months ended in Sep. 2023 was £0.16 Mil. ReNeuron Group's Revenue for the six months ended in Sep. 2023 was £0.16 Mil. Therefore, ReNeuron Group's Gross Margin % for the quarter that ended in Sep. 2023 was N/A%.

ReNeuron Group had a gross margin of N/A% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage


ReNeuron Group Gross Profit Historical Data

The historical data trend for ReNeuron Group's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Gross Profit Chart

ReNeuron Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 6.07 0.26 0.40 0.53

ReNeuron Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.35 0.44 0.09 0.16

Competitive Comparison of ReNeuron Group's Gross Profit

For the Biotechnology subindustry, ReNeuron Group's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ReNeuron Group's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ReNeuron Group's Gross Profit distribution charts can be found below:

* The bar in red indicates where ReNeuron Group's Gross Profit falls into.



ReNeuron Group Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

ReNeuron Group's Gross Profit for the fiscal year that ended in Mar. 2023 is calculated as

Gross Profit (A: Mar. 2023 )=Revenue - Cost of Goods Sold
=0.53 - 0
=0.53

ReNeuron Group's Gross Profit for the quarter that ended in Sep. 2023 is calculated as

Gross Profit (Q: Sep. 2023 )=Revenue - Cost of Goods Sold
=0.157 - 0
=0.16

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.25 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

ReNeuron Group's Gross Margin % for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.16 / 0.157
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


ReNeuron Group  (LSE:RENE) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

ReNeuron Group had a gross margin of N/A% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage


ReNeuron Group Gross Profit Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


ReNeuron Group (LSE:RENE) Business Description

Traded in Other Exchanges
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.